Journal of Neuropathology & Experimental Neurology,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Jan. 20, 2025
Abstract
Chitinase
3-like
protein
1
(CHI3L1)
is
emerging
as
a
promising
biomarker
for
assessing
intracranial
lesion
burden
and
predicting
prognosis
in
traumatic
brain
injury
(TBI)
patients.
Following
experimental
TBI,
Chi3l1
transcripts
were
detected
reactive
astrocytes
located
within
the
pericontusional
cortex.
However,
cellular
sources
of
CHI3L1
response
to
hemorrhagic
contusions
human
remain
unidentified.
Hence,
we
examined
comprehensive
collection
histologically
defined
acute
subacute
cerebral
with
various
surgical
intervals
using
immunohistochemistry,
validated
through
double
immunofluorescence
markers
such
GFAP,
NeuN,
MBP,
Iba-1,
along
Fluoro-Jade
C
histofluorescence
staining.
was
found
at
meningeal
interfaces,
showing
significant
thickening
subpial
glial
plate.
Paradoxically,
CHI3L1-positive
identified
neuroanatomical
locations
distant
from
foci,
where
numerous
eosinophilic
ischemic
neurons
also
exhibited
immunoreactivity.
immunostaining
extended
into
white
matter
tracts
highlighted
phagocytic
or
activated
microglia
forms
after
delayed
decompressions.
Given
these
findings,
advise
against
astrogliosis
marker
due
its
expression
multiple
cell
types,
including
astrocytes,
neurons,
oligodendrocytes,
ependymocytes,
leptomeningeal
cells,
microglia,
blood
vessels.
This
non-selective
underscores
potential
elevation
patterns
biofluids
reflect
overall
extent.
Cell Reports,
Journal Year:
2024,
Volume and Issue:
43(5), P. 114226 - 114226
Published: May 1, 2024
Cognitive
dysfunction
is
a
feature
in
multiple
sclerosis
(MS),
chronic
inflammatory
demyelinating
disorder.
A
notable
aspect
of
MS
brains
hippocampal
demyelination,
which
closely
associated
with
cognitive
decline.
However,
the
mechanisms
underlying
this
phenomenon
remain
unclear.
Chitinase-3-like
(CHI3L1),
secreted
by
activated
astrocytes,
has
been
identified
as
biomarker
for
progression.
Our
study
investigates
CHI3L1's
function
within
hippocampus
and
demonstrates
correlation
between
CHI3L1
expression
impairment
patients
MS.
Activated
astrocytes
release
reaction
to
induced
adversely
affects
proliferation
differentiation
neural
stem
cells
impairs
dendritic
growth,
complexity,
spine
formation
neurons.
findings
indicate
that
astrocytic
deletion
can
mitigate
neurogenic
deficits
dysfunction.
We
showed
interacts
CRTH2/receptor
advanced
glycation
end
(RAGE)
attenuating
β-catenin
signaling.
The
reactivation
signaling
revitalize
neurogenesis,
holds
promise
therapy
demyelination.
Biomaterials Research,
Journal Year:
2023,
Volume and Issue:
27(1)
Published: Feb. 9, 2023
Brain-derived
exosomes
released
into
the
blood
are
considered
a
liquid
biopsy
to
investigate
pathophysiological
state,
reflecting
aberrant
heterogeneous
pathways
of
pathological
progression
brain
in
neurological
diseases.
provide
promising
prospects
for
diagnosis
diseases,
with
exciting
possibilities
early
and
sensitive
such
However,
capability
traditional
exosome
isolation
assays
specifically
isolate
characterize
brain-derived
exosomal
proteins
by
high-throughput
proteomics
clinical
specimens
from
patients
diseases
cannot
be
assured.
We
report
magnetic
transferrin
nanoparticles
(MTNs)
assay,
which
combined
samples.The
principle
MTNs
assay
is
ligand-receptor
interaction
through
on
receptor
exosomes,
electrostatic
via
positively
charged
negatively
exosomes.
In
addition,
simple
rapid
(<
35
min)
does
not
require
any
large
instrument.
confirmed
that
accurately
efficiently
isolated
serum
samples
humans
neurodegenerative
as
dementia,
Parkinson's
disease
(PD),
multiple
sclerosis
(MS).
Moreover,
we
30
three
distinct
performed
unbiased
proteomic
analysis
explore
pilot
value
protein
profiles
biomarkers.Using
comparative
statistical
analysis,
found
21
candidate
biomarkers
were
significantly
different
among
groups
diseases.The
convenient
approach
specific
affordable
extracellular
vesicles
body
fluids
minimally-invasive
Biomarker Research,
Journal Year:
2023,
Volume and Issue:
11(1)
Published: Jan. 31, 2023
Niemann-Pick
disease,
type
C1
(NPC1)
is
an
ultrarare,
recessive,
lethal,
lysosomal
disease
characterized
by
progressive
cerebellar
ataxia
and
cognitive
impairment.
Although
the
NPC1
phenotype
heterogeneous
with
variable
age
of
onset,
classical
a
pediatric
disorder.
Currently
there
are
no
therapies
approved
FDA
therapeutics
trials
for
complicated
rarity,
heterogeneity,
relatively
slow
rate
neurological
decline.
Thus,
identification
relevant
biomarkers
necessary
to
provide
tools
that
can
support
drug
development
efforts
this
devastating
disease.
Proximal
extension
assays
(O-link®
Explore
1536)
were
used
compare
cerebrospinal
fluid
(CSF)
samples
from
individuals
enrolled
in
natural
history
study
non-NPC1
comparison
samples.
Relative
expression
levels
1467
proteins
determined,
candidate
protein
identified
evaluating
fold-change
adjusted
Kruskal-Wallis
test
p-values.
Selected
orthogonally
confirmed
using
ELISA.
To
gain
insight
into
progression
severity
we
evaluated
altered
respect
clinically
phenotypic
aspects:
NPC
Neurological
Severity
Score
(NPC1
NSS),
Annual
Increment
(ASIS)
onset.
This
multiple
CSF
compared
These
included
previously
shown
be
elevated
(NEFL,
MAPT,
CHIT1,
CALB1)
additional
orthogonal
(PARK7,
CALB2/calretinin,
CHI3L1/YKL-40,
MIF,
CCL18
ENO2).
Correlations
parameters
demonstrated
moderate
negative
(p
=
0.0210,
r
-0.41)
possible
positive
0.0631,
0.33)
correlation
CALB2
onset
ASIS,
respectively.
CHI3L1
showed
0.0183,
0.40)
concurrent
NSS.
A
strong
0.0016,
-0.648)
was
observed
between
childhood/adolescent
cases.
also
0.0017,
0.61)
ASIS.
Our
validated
candidates
further
investigation
larger
cohort.
analytes
may
prove
useful
as
supportive
data
therapeutic
trials.
NCT00344331,
NCT00001721,
NCT02931682.
International Journal of Molecular Sciences,
Journal Year:
2023,
Volume and Issue:
24(22), P. 16149 - 16149
Published: Nov. 9, 2023
Chitinase-3-like
protein
1
(CHI3L1),
a
chitinase-like
family
member,
is
secreted
glycoprotein
that
mediates
macrophage
polarization,
inflammation,
apoptosis,
angiogenesis,
and
carcinogenesis.
Abnormal
CHI3L1
expression
has
been
associated
with
multiple
metabolic
neurological
disorders,
including
diabetes,
atherosclerosis,
Alzheimer’s
disease.
Aberrant
also
reportedly
tumor
migration
metastasis,
as
well
contributions
to
immune
escape,
playing
important
roles
in
progression.
However,
the
physiological
pathophysiological
of
development
neurodegenerative
diseases
cancer
remain
unclear.
Understanding
polarization
relationship
between
macrophages
crucial
for
disease
Recent
research
uncovered
complex
mechanisms
different
diseases,
highlighting
its
close
association
functional
polarization.
In
this
article,
we
review
recent
findings
regarding
various
types
summarize
CHI3L1.
Furthermore,
article
provides
brief
overview
inhibitors
employed
inhibit
disrupt
interaction
receptors.
These
endeavors
highlight
pivotal
suggest
therapeutic
approaches
targeting
cancers.
Neurological Sciences,
Journal Year:
2024,
Volume and Issue:
45(6), P. 2489 - 2503
Published: Jan. 9, 2024
Abstract
Amyotrophic
lateral
sclerosis
(ALS)
is
a
fatal
neurodegenerative
disease
characterized
by
the
degeneration
of
motor
neurons,
and
there
currently
lack
reliable
diagnostic
biomarkers.
This
meta-analysis
aimed
to
evaluate
CHIT1,
CHI3L1,
CHI3L2
levels
in
cerebrospinal
fluid
(CSF)
or
blood
their
potential
ALS
patients.
A
systematic,
comprehensive
search
was
performed
peer-reviewed
English-language
articles
published
before
April
1,
2023,
PubMed,
Scopus,
Embase,
Cochrane
Library,
Web
Science.
After
thorough
screening,
13
primary
were
included,
chitinases-related
data
extracted
for
systematic
review
meta-analysis.
In
patients,
CSF
CHIT1
significantly
elevated
compared
controls
with
healthy
control
(HC)
(SMD,
1.92;
95%
CI,
0.78
–
3.06;
P
<
0.001).
patients
other
diseases
(ONDS)
0.74;
0.22
1.27;
0.001)
exhibited
an
even
more
substantial
increase
when
ALS-mimicking
(AMDS)
1.15;
0.35
1.94,
Similarly,
CHI3L1
higher
HC
3.16;
1.26
5.06,
ONDS
0.75;
0.32
1.19;
=
0.017)
pronounced
AMDS
0.41
3.42;
The
chitinases
showed
significant
increase,
supporting
role
as
biomarkers
ALS.
International Journal of Molecular Sciences,
Journal Year:
2024,
Volume and Issue:
25(10), P. 5550 - 5550
Published: May 19, 2024
Several
clinical
studies
reported
that
the
elevated
expression
of
Chitinase-3-like
1
(CHI3L1)
was
observed
in
patients
suffering
from
a
wide
range
diseases:
cancer,
metabolic,
and
neurological
diseases.
However,
role
CHI3L1
AD
is
still
unclear.
Our
previous
study
demonstrated
2-({3-[2-(1-Cyclohexen-1-yl)ethyl]-6,7-dimethoxy-4-oxo-3,4-dihydro-2-quinazolinyl}culfanyl)-
Genome Medicine,
Journal Year:
2023,
Volume and Issue:
15(1)
Published: Oct. 4, 2023
Genome-wide
association
studies
(GWAS)
of
Alzheimer's
disease
(AD)
have
identified
several
risk
loci,
but
many
remain
unknown.
Cerebrospinal
fluid
(CSF)
biomarkers
may
aid
in
gene
discovery
and
we
previously
demonstrated
that
six
CSF
(β-amyloid,
total/phosphorylated
tau,
NfL,
YKL-40,
neurogranin)
cluster
into
five
principal
components
(PC),
each
representing
statistically
independent
biological
processes.
Here,
aimed
to
(1)
identify
common
genetic
variants
associated
with
these
profiles,
(2)
assess
the
role
AD
pathophysiology,
(3)
explore
potential
sex
differences.
Cells,
Journal Year:
2024,
Volume and Issue:
13(8), P. 678 - 678
Published: April 14, 2024
Chitinase
3-like
1
(also
known
as
CHI3L1
or
YKL-40)
is
a
mammalian
chitinase
that
has
no
enzymatic
activity,
but
the
ability
to
bind
chitin,
polymer
of
N-acetylglucosamine
(GlcNAc).
Chitin
component
fungi,
crustaceans,
arthropods
including
insects
and
mites,
parasites,
it
completely
absent
from
mammals,
humans
mice.
In
general,
chitin-containing
organisms
produce
chitinases,
such
CHI3L1,
protect
body
exogenous
pathogens
well
hostile
environments,
was
thought
had
similar
effect
in
mammals.
However,
recent
studies
have
revealed
plays
pathophysiological
role
by
inducing
anti-apoptotic
activity
epithelial
cells
macrophages.
Under
chronic
inflammatory
conditions
bowel
disease
obstructive
pulmonary
disease,
many
groups
already
confirmed
expression
significantly
induced
on
apical
side
cells,
activates
downstream
pathways
involved
inflammation
carcinogenesis.
this
review
article,
we
summarize
under
various
disorders
discuss
potential
roles
those
cell
types.
Aging Clinical and Experimental Research,
Journal Year:
2022,
Volume and Issue:
35(1), P. 117 - 126
Published: Nov. 1, 2022
Abstract
Background
Inflammatory
responses
play
key
roles
in
the
development
and
progression
of
many
pathological
conditions,
including
neurodegenerative
diseases.
Accurate
quantification
inflammatory
factors
saliva
would
be
highly
advantageous,
given
its
convenience
non-invasive
nature,
especially
elderly
populations.
Methods
In
this
study,
we
measured
levels
10
cytokines,
pro-inflammatory
factor,
YKL-40,
plasma
samples
from
a
cohort
nondemented
older
adults
(
n
=
71;
62%
female;
70.3
±
6.4
years)
using
sensitive
electrochemiluminescence-based
immunoassays.
Results
We
found
that
mean
all
cytokines
were
higher
compared
to
strong
sex
differences
observed
for
both
population.
Comparing
each
cytokine
between
two
biofluids,
interferon-gamma
(IFNγ),
interleukin
(IL)-6
tumor
necrosis
factor-alpha
(TNFα)
blood
significantly
correlated
with
their
respective
saliva.
further
these
additional
saliva,
IL-1β,
IL-10,
IL-8,
IL12p70
IL-13.
Conclusions
These
findings
show
markers
are
associated
those
circulation,
suggesting
shared
mechanisms
fluids.
The
suggest
it
might
represent
better
peripheral
fluid
gauge
processes.
Finally,
our
robust
several
salivary
could
have
important
implications
potential
use
as
disease
biomarkers
related
prevalence
age-related
conditions.
The Journal of Infectious Diseases,
Journal Year:
2024,
Volume and Issue:
230(3), P. e732 - e736
Published: Feb. 14, 2024
Abstract
Progressive
multifocal
leukoencephalopathy
(PML)
is
a
rare
neurological
condition
associated
with
reactivation
of
dormant
JC
polyomavirus
(JCPyV).
In
this
study,
we
characterized
gene
expression
and
JCPyV
rearrangements
in
PML
brain
tissue.
Infection
white
matter
astrocytes
oligodendrocytes
as
well
occasional
cortex
neurons
was
shown.
harbored
exclusively
rearranged
variants.
Viral
transcripts
covered
the
whole
genome
on
both
strands.
Strong
differential
human
genes
neuroinflammation,
blood-brain
barrier
permeability,
neurodegenerative
diseases
Pathway
analysis
revealed
wide
immune
activation
brain.
The
study
provides
novel
insights
into
pathogenesis
PML.